Thus, the reduction in the expression of ELOVL5 or IGFBP6 genes leads to increased sensitivity to the induction of ferroptosis in breast cancer cells and at the same time makes them more responsive to its inhibition. The gene discussed is IGFBP6; the disease is breast carcinoma.